CY2329B1 - Compositions containing micronized nebivolol. - Google Patents
Compositions containing micronized nebivolol.Info
- Publication number
- CY2329B1 CY2329B1 CY0200045A CY0200045A CY2329B1 CY 2329 B1 CY2329 B1 CY 2329B1 CY 0200045 A CY0200045 A CY 0200045A CY 0200045 A CY0200045 A CY 0200045A CY 2329 B1 CY2329 B1 CY 2329B1
- Authority
- CY
- Cyprus
- Prior art keywords
- pct
- compositions containing
- containing micronized
- micronized nebivolol
- sec
- Prior art date
Links
- KOHIRBRYDXPAMZ-YHBROIRLSA-N (S,R,R,R)-nebivolol Chemical compound C1CC2=CC(F)=CC=C2O[C@H]1[C@H](O)CNC[C@@H](O)[C@H]1OC2=CC=C(F)C=C2CC1 KOHIRBRYDXPAMZ-YHBROIRLSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229960000619 nebivolol Drugs 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19798894A | 1994-02-17 | 1994-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY2329B1 true CY2329B1 (en) | 2004-02-06 |
Family
ID=22731545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY0200045A CY2329B1 (en) | 1994-02-17 | 2002-07-15 | Compositions containing micronized nebivolol. |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5759580A (ja) |
| EP (1) | EP0744946B1 (ja) |
| JP (1) | JP3810079B2 (ja) |
| KR (1) | KR100361636B1 (ja) |
| CN (1) | CN1112921C (ja) |
| AT (1) | ATE212547T1 (ja) |
| AU (1) | AU688860B2 (ja) |
| BR (1) | BR9506828A (ja) |
| CA (1) | CA2182582C (ja) |
| CY (1) | CY2329B1 (ja) |
| CZ (1) | CZ290844B6 (ja) |
| DE (1) | DE69525241T2 (ja) |
| DK (1) | DK0744946T3 (ja) |
| ES (1) | ES2171533T3 (ja) |
| FI (1) | FI117888B (ja) |
| HU (1) | HU221848B1 (ja) |
| IL (1) | IL112659A (ja) |
| MX (1) | MX9603314A (ja) |
| MY (1) | MY115339A (ja) |
| NO (1) | NO314712B1 (ja) |
| NZ (1) | NZ279822A (ja) |
| PL (1) | PL178505B1 (ja) |
| PT (1) | PT744946E (ja) |
| RU (1) | RU2137473C1 (ja) |
| SG (1) | SG47487A1 (ja) |
| SI (1) | SI0744946T1 (ja) |
| SK (1) | SK283250B6 (ja) |
| TW (1) | TW355683B (ja) |
| WO (1) | WO1995022325A1 (ja) |
| ZA (1) | ZA951294B (ja) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU226208B1 (en) * | 1994-12-28 | 2008-06-30 | Janssen Pharmaceutica Nv | Use of nebivolol for producing anti-atherogenic pharmaceuticals |
| DE69615704T2 (de) | 1995-12-27 | 2002-07-11 | Janssen Pharmaceutica N.V., Beerse | Bioadhesive feste arzneimittelform |
| DE19637082A1 (de) | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
| US7025991B2 (en) * | 1997-06-13 | 2006-04-11 | Nanodel Technologies Gmbh | Drug targeting system, method of its preparation and its use |
| AR016827A1 (es) | 1997-08-22 | 2001-08-01 | Smithkline Beecham Corp | PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA |
| AR017512A1 (es) | 1997-08-22 | 2001-09-12 | Smithkline Beecham Corp | Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas |
| US20030152636A1 (en) * | 2000-02-23 | 2003-08-14 | Nanopharm Ag | Method of treating cancer |
| US6531158B1 (en) * | 2000-08-09 | 2003-03-11 | Impax Laboratories, Inc. | Drug delivery system for enhanced bioavailability of hydrophobic active ingredients |
| ATE437637T1 (de) * | 2001-05-02 | 2009-08-15 | Nitromed Inc | Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren |
| US7803838B2 (en) * | 2004-06-04 | 2010-09-28 | Forest Laboratories Holdings Limited | Compositions comprising nebivolol |
| RU2378272C2 (ru) | 2004-07-30 | 2010-01-10 | Торрент Фармасьютикалз Лимитед | Небиволол и его фармацевтически приемлемые соли, способ их получения и фармацевтические композиции небиволола |
| US20070021623A1 (en) * | 2004-08-11 | 2007-01-25 | Hetero Drugs Limited | Novel process for preparation of nebivolol intermediates |
| US7344907B2 (en) * | 2004-11-19 | 2008-03-18 | International Business Machines Corporation | Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale |
| EP1848424B1 (en) * | 2005-01-31 | 2017-04-05 | Mylan Laboratories, Inc | Pharmaceutical composition comprising hydroxylated nebivolol |
| WO2006084684A1 (de) * | 2005-02-11 | 2006-08-17 | Stada Arzneimittel Ag | Pharmazeutische zusammensetzungen nebivolo und ein hydrophiles polymer |
| EP1803716B1 (en) * | 2005-12-28 | 2012-07-25 | Acino Pharma AG | A process for preparation of racemic nebivolol |
| US7560575B2 (en) | 2005-12-28 | 2009-07-14 | Acino Pharma Ag | Process for preparation of racemic Nebivolol |
| WO2007083318A1 (en) * | 2006-01-18 | 2007-07-26 | Hetero Drugs Limited | Process for isolation of desired isomers of nebivolol intermediates |
| EP1839658A1 (en) * | 2006-03-30 | 2007-10-03 | Hexal A/S | Pharmaceutical composition comprising micronized nebivolol |
| DE102006036579A1 (de) * | 2006-08-04 | 2008-02-07 | Alfred E. Tiefenbacher Gmbh & Co.Kg | Pharmazeutische Zusammensetzung |
| ATE462415T1 (de) * | 2006-08-04 | 2010-04-15 | Alfred E Tiefenbacher Gmbh & C | Pharmazeutische zusammensetzung enthaltend nebivolol |
| UA97813C2 (uk) * | 2006-12-05 | 2012-03-26 | Янссен Фармацевтика Н.В. | Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу |
| WO2008089549A1 (en) * | 2007-01-22 | 2008-07-31 | Genpharm Ulc | Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| US20100172972A1 (en) * | 2007-05-21 | 2010-07-08 | Sun Pharmaceutical Industries Limited | Enteric coated pharmaceutical compositions |
| US20090030071A1 (en) * | 2007-07-26 | 2009-01-29 | Shaw Andrew A | Treatment of Cardiovascular Disease in Mexican Americans Using Nebivolol |
| CN101463024B (zh) | 2007-12-21 | 2011-06-08 | 上海现代制药股份有限公司 | 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法 |
| US20090181975A1 (en) * | 2008-01-15 | 2009-07-16 | Forest Laboratories Holdings Limited | Nebivolol in the treatment of sexual dysfunction |
| ATE533752T1 (de) | 2008-09-08 | 2011-12-15 | Cadila Pharmaceuticals Ltd | Verbesserter herstellungsprozess für nebivolol- hydrocholorid |
| IT1395354B1 (it) | 2009-07-23 | 2012-09-14 | Zach System Spa | Processo di preparazione di nebivololo |
| IT1397962B1 (it) | 2010-02-11 | 2013-02-04 | Menarini Int Operations Lu Sa | Processo per la preparazione del nebivololo. |
| KR20110130872A (ko) * | 2010-05-28 | 2011-12-06 | 현대약품 주식회사 | 결정형 염산 네비볼롤을 포함하는 약학 조성물 및 제조방법 |
| WO2012003181A2 (en) * | 2010-07-02 | 2012-01-05 | Fmc Corporation | Solid forms |
| CN105085499B (zh) * | 2015-08-07 | 2018-09-25 | 上海现代制药海门有限公司 | 盐酸奈必洛尔中间体混合物的结晶分离方法 |
| CN117503775A (zh) | 2017-04-28 | 2024-02-06 | 自由生物有限公司 | 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型 |
| US20220016025A1 (en) * | 2020-07-08 | 2022-01-20 | Vinayak Dinesh DENDUKURI | Formulations of nebivolol |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60107106A (ja) * | 1983-11-15 | 1985-06-12 | Mitsubishi Electric Corp | 曲線補間装置 |
| CA1337429C (en) * | 1983-12-05 | 1995-10-24 | Guy Rosalia Eugene Van Lommen | Derivatives of 2,2'-iminobisethanol |
| CA1337432C (en) * | 1988-03-23 | 1995-10-24 | Raymond M. Xhonneux | Method of lowering the blood pressure |
| JPH02264744A (ja) * | 1989-04-04 | 1990-10-29 | Kyowa Hakko Kogyo Co Ltd | 光学活性なｐ―フルオロフェノキシ誘導体およびその製造法 |
-
1995
- 1995-01-17 TW TW084100357A patent/TW355683B/zh not_active IP Right Cessation
- 1995-02-10 HU HU9602272A patent/HU221848B1/hu active IP Right Grant
- 1995-02-10 SI SI9530582T patent/SI0744946T1/xx unknown
- 1995-02-10 AU AU17068/95A patent/AU688860B2/en not_active Expired
- 1995-02-10 SG SG1996002228A patent/SG47487A1/en unknown
- 1995-02-10 EP EP95908927A patent/EP0744946B1/en not_active Expired - Lifetime
- 1995-02-10 KR KR1019960704263A patent/KR100361636B1/ko not_active IP Right Cessation
- 1995-02-10 US US08/669,415 patent/US5759580A/en not_active Expired - Lifetime
- 1995-02-10 WO PCT/EP1995/000489 patent/WO1995022325A1/en active IP Right Grant
- 1995-02-10 ES ES95908927T patent/ES2171533T3/es not_active Expired - Lifetime
- 1995-02-10 DK DK95908927T patent/DK0744946T3/da active
- 1995-02-10 RU RU96118271A patent/RU2137473C1/ru active
- 1995-02-10 PT PT95908927T patent/PT744946E/pt unknown
- 1995-02-10 JP JP52156295A patent/JP3810079B2/ja not_active Expired - Lifetime
- 1995-02-10 BR BR9506828A patent/BR9506828A/pt not_active IP Right Cessation
- 1995-02-10 PL PL95315973A patent/PL178505B1/pl unknown
- 1995-02-10 DE DE69525241T patent/DE69525241T2/de not_active Expired - Lifetime
- 1995-02-10 CZ CZ19962346A patent/CZ290844B6/cs not_active IP Right Cessation
- 1995-02-10 AT AT95908927T patent/ATE212547T1/de active
- 1995-02-10 CN CN95191662A patent/CN1112921C/zh not_active Expired - Lifetime
- 1995-02-10 MX MX9603314A patent/MX9603314A/es unknown
- 1995-02-10 CA CA002182582A patent/CA2182582C/en not_active Expired - Fee Related
- 1995-02-10 SK SK1058-96A patent/SK283250B6/sk not_active IP Right Cessation
- 1995-02-10 NZ NZ279822A patent/NZ279822A/en not_active IP Right Cessation
- 1995-02-15 IL IL11265995A patent/IL112659A/xx not_active IP Right Cessation
- 1995-02-16 MY MYPI95000396A patent/MY115339A/en unknown
- 1995-02-16 ZA ZA951294A patent/ZA951294B/xx unknown
-
1996
- 1996-08-16 NO NO19963439A patent/NO314712B1/no not_active IP Right Cessation
- 1996-08-16 FI FI963227A patent/FI117888B/fi not_active IP Right Cessation
-
2002
- 2002-07-15 CY CY0200045A patent/CY2329B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA951294B (en) | Compositions containing micronized nebivolot | |
| DE69522947D1 (en) | Phenylxanthin-derivate | |
| AU4264396A (en) | Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof | |
| IL108520A0 (en) | Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them | |
| IL110582A (en) | Substituted azadioxacycloalkenes their preparation and fungicidal compositions containing them | |
| IL110494A0 (en) | Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them | |
| HU9601218D0 (en) | Distamycin a analogue utilizable as antitumoral and antiviral medicines | |
| IL114598A0 (en) | Triazole compounds their preparation and pharmaceutical compositions containing them | |
| IL114241A0 (en) | Thiazolidine derivatives their preparation and compositions containing them | |
| FI972434A0 (fi) | Lamotrigiiniä sisältävä farmaseuttinen koostumus | |
| HU9601511D0 (en) | N-substituted azabicycloheptane derivatives used, for example, as neuroleptics | |
| HU9602413D0 (en) | Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same | |
| SG82540A1 (en) | N-substituted azabicyclo [3.2.0] heptane derivatives as neuroleptics, the preparation and use thereof | |
| IL108288A0 (en) | Pyrrolidine derivatives, their preparation and medicaments containing them | |
| IL114719A0 (en) | N-substituted azabicycloheptane derivatives their preparation and use thereof | |
| IL107520A0 (en) | Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them | |
| TW261605B (ja) |